NR565 ADVANCED PHARMACOLOGY FINAL – CHAMBERLAIN 2026/2027 | 100 HIGH-YIELD QUESTIONS & VERIFIED ANSWERS | LATEST TEST PR

The NR565 Advanced Pharmacology Final from Chamberlain for the academic years 2026/2027 offers a comprehensive study guide with 100 high-yield questions and verified answers. This essential test preparation resource is tailored for students seeking to excel in advanced pharmacology, focusing on the most recent and frequently tested topics. The document includes a wide array of questions covering contraindications, lab values, and therapeutic goals for various medications, making it an invaluable tool for A+ preparation.

Key topics include the contraindication of Metformin in alcoholics and its association with specific lab values like eGFR <30. The guide also addresses the use of Thiazolidinediones in diabetic patients with specific cardiac conditions and delves into asthma management, highlighting treatment strategies such as Short-Acting Beta Agonists (SABA) for step 1 therapy and inhaled corticosteroids (ICS) to control airway inflammation. Additionally, it explores the classification of asthma severity, focusing on severe asthma management.

The document also covers advanced pharmacological concepts such as the mechanism of action of DPP4 inhibitors and GLP-1 receptor agonists, emphasizing their role in insulin secretion and glucose control. Students will gain insights into the use of decongestants, tuberculosis prevention with Isoniazid, and first-line therapies for COPD and asthma, such as Levalbuterol. This guide is designed to equip students with the knowledge needed to succeed in advanced pharmacology exams, making it a must-have for any aspiring healthcare professional.